KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Total Debt (2017 - 2021)

Historic Total Debt for Co-Diagnostics (CODX) over the last 5 years, with Q3 2021 value amounting to $60000.0.

  • Co-Diagnostics' Total Debt fell 6666.67% to $60000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $60000.0, marking a year-over-year decrease of 6666.67%. This contributed to the annual value of $150000.0 for FY2020, which is 4444.44% down from last year.
  • As of Q3 2021, Co-Diagnostics' Total Debt stood at $60000.0, which was down 6666.67% from $180000.0 recorded in Q2 2021.
  • Co-Diagnostics' 5-year Total Debt high stood at $855868.0 for Q2 2017, and its period low was $60000.0 during Q3 2021.
  • Over the past 5 years, Co-Diagnostics' median Total Debt value was $395000.0 (recorded in 2018), while the average stood at $380414.4.
  • Examining YoY changes over the last 5 years, Co-Diagnostics' Total Debt showed a top increase of 0.0% in 2021 and a maximum decrease of 6666.67% in 2021.
  • Quarter analysis of 5 years shows Co-Diagnostics' Total Debt stood at $600000.0 in 2017, then plummeted by 36.67% to $380000.0 in 2018, then fell by 28.95% to $270000.0 in 2019, then plummeted by 44.44% to $150000.0 in 2020, then tumbled by 60.0% to $60000.0 in 2021.
  • Its last three reported values are $60000.0 in Q3 2021, $180000.0 for Q2 2021, and $240000.0 during Q1 2021.